{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:26:34Z","timestamp":1757611594698,"version":"3.44.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Acromegaly is a rare disease frequently caused by a growth hormone-secreting pituitary adenoma (GHPA), and neuroimaging plays an important role in tumor localization, characterization, and surgical planning. A 57-year-old man underwent <jats:sup>68<\/jats:sup>Ga-DOTATOC PET\/CT for an incidental pancreatic lesion. The PET revealed an increased radiotracer uptake and enlargement of the pituitary gland. The study was completed with <jats:sup>18<\/jats:sup>F-FDOPA and <jats:sup>18<\/jats:sup>F-FDG PET\/MRI, which revealed a sellar lesion suggesting pituitary adenoma. Pathological examination of the resected tumor confirmed a GHPA.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005937","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T01:00:11Z","timestamp":1751245211000},"page":"e614-e616","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["68Ga- DOTATOC PET\/CT, 18F-FDOPA, and 18F-FDG PET\/MR Findings in Growth Hormone-secreting Pituitary Adenoma"],"prefix":"10.1097","volume":"50","author":[{"given":"Marina","family":"Su\u00e1rez-Pi\u00f1era","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Castell-Aulet","sequence":"additional","affiliation":[{"name":"Diagnostic Imaging"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Ruiz-Roig","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rodriguez-Bel","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fern\u00e1ndo","family":"Guerrero-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Endocrinology Bellvitge University Hospital, L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"R1-20250903","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2019.08.008","article-title":"The pituitary in nuclear medicine imaging","volume":"68","author":"Iglesias","year":"2019","journal-title":"Eur J Intern Med"},{"key":"R2-20250903","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/RLU.0000000000001721","article-title":"18F-FDOPA PET imaging in prolactinoma","volume":"42","author":"Ginet","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R3-20250903","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RLU.0000000000002202","article-title":"18F-FDOPA uptake reflects the efficacy of dopamine agonists treatment in pituitary prolactinoma","volume":"43","author":"Heimburger","year":"2018","journal-title":"Clin Nucl Med"},{"key":"R4-20250903","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/RLU.0000000000001085","article-title":"Utility of 11C-methionine and 18F-FDG PET\/CT in Patients with functioning pituitary adenomas","volume":"41","author":"Feng","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R5-20250903","doi-asserted-by":"crossref","first-page":"101278","DOI":"10.1016\/j.beem.2019.05.002","article-title":"Modern imaging of pituitary adenomas","volume":"33","author":"Bashari","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R6-20250903","doi-asserted-by":"crossref","first-page":"110868","DOI":"10.1016\/j.mce.2020.110868","article-title":"L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells","volume":"515","author":"Satou","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"R7-20250903","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RLU.0000000000002202","article-title":"A. 18F-FDOPA uptake reflects the efficacy of dopamine agonists treatment in pituitary prolactinoma","volume":"43","author":"Heimburger","year":"2018","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:00:18Z","timestamp":1756933218000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005937","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"2024-11-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}